Current position:Home >Product >
N-[1-(2-azanyl-2-oxidanylidene-ethyl)piperidin-4-yl]-4-(5-phenyl-1,3,4-oxadiazol-2-yl)benzamide
N-[1-(2-azanyl-2-oxidanylidene-ethyl)piperidin-4-yl]-4-(5-phenyl-1,3,4-oxadiazol-2-yl)benzamide
|
|
Canonical SMILES:
C1CN(CCC1NC(=O)C2=CC=C(C=C2)C3=NN=C(O3)C4=CC=CC=C4)CC(=O)N
Isomeric SMILES
C1CN(CCC1NC(=O)C2=CC=C(C=C2)C3=NN=C(O3)C4=CC=CC=C4)CC(=O)N
InChI
InChI=1S/C22H23N5O3/c23-19(28)14-27-12-10-18(11-13-27)24-20(29)15-6-8-17(9-7-15)22-26-25-21(30-22)16-4-2-1-3-5-16/h1-9,18H,10-14H2,(H2,23,28)(H,24,29)
Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- N-(5,6-dimethoxy-1,3-benzothiazol-2-yl)-3-(3-methoxyphenyl)propanamide
- 3-(4-oxidanylidene-5,6,7,8-tetrahydro-3H-[1]benzothiolo[2,3-d]pyrimidin-2-yl)-N-(6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-ylmethyl)propanamide
- N-[2-[4-[(4-methoxyphenyl)methyl]-1,4-diazepan-1-yl]-2-oxidanylidene-ethyl]-1,3-benzodioxole-5-carboxamide
- 5-bromanyl-N-[2-[4-[(4-methoxyphenyl)methyl]-1,4-diazepan-1-yl]-2-oxidanylidene-ethyl]furan-2-carboxamide
- N-[2-[4-[(4-methoxyphenyl)methyl]-1,4-diazepan-1-yl]-2-oxidanylidene-ethyl]-3,4-dimethyl-benzamide
- 3-[3-[4-[(4-methoxyphenyl)methyl]-1,4-diazepan-1-yl]-3-oxidanylidene-propyl]-2-sulfanylidene-1H-quinazolin-4-one
- [4-[(4-methoxyphenyl)methyl]-1,4-diazepan-1-yl]-[4-[(2-methyl-1,3-thiazol-4-yl)methoxy]phenyl]methanone
- 2,4-bis(chloranyl)-N-[3-methyl-1-oxidanylidene-1-(6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-ylmethylamino)butan-2-yl]benzamide
- [4-[(4-methoxyphenyl)methyl]-1,4-diazepan-1-yl]-[2-(4-methoxyphenyl)-4-methyl-1,3-thiazol-5-yl]methanone
- 1-[3-chloranyl-5-(trifluoromethyl)pyridin-2-yl]-N-(6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-ylmethyl)piperidine-4-carboxamide

